Family Office
Andreas Struengmann & Family
Andreas Struengmann and twin brother Thomas were early backers of BioNTech, which partnered with Pfizer to make a vaccine for Covid-19. The brothers cofounded generic drugmaker Hexal in 1986 and sold it to Novartis in 2005 for some $7 billion. The brothers invest in biotech, pharma, life sciences and healthcare compani…
Headquarters
Germany
Asset classes & sectors
HealthcarePharmaceuticals
Decision-makers
Decision-maker details available to members.
Members only
Unlock contacts, warm paths & full holdings
See who to reach, how you're connected, the check sizes, and the full mandate — across Andreas Struengmann & Family and 500k+ investors and LPs.